VC firm Peak XV Partners’ managing director Rajan Anandan has said that the deeptech sector is the “final frontier” for the ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

The company said that ZAMTO Cell is designed to target both CD19 and CD20, which could improve treatment efficacy.

For decades, Bharat Biotech has led India’s effort in developing and manufacturing affordable vaccines for critical diseases. CGT aligns with BBIL’s broader vision of expanding beyond ...

Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in three years. The company is targeting oncology and rare ...

Bharat Biotech said it intends to focus more on the latter. India, compared to global peers, is still in the nascent stages of cell and gene therapy development with barely any adoption. Ella said ...

Commenting on the purpose behind establishing India’s only vertically integrated cell and gene therapy facility, Krishna Ella, executive chairman, Bharat Biotech, said, “Gene and cell therapies ...

In a significant push towards technology-driven collaboration and investment in India’s biotech sector, Microsoft co-founder and philanthropist Bill Gates met with India’s Union Minister of Science ...

The film was released across India on February 14, 2025. According to the police, a case has been filed regarding illegal online distribution of the Hindi film Chhaava. The complaint was made by ...

Hyderabad: Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced on Thursday the launch of India’s only vertically integrated ...

Comedian Samay Raina announced on Thursday evening that he would be rescheduling his upcoming India tour. The 27-year-old shared the news with his followers through an Instagram story, stating ...

Hyderabad (Telangana) [India], March 20 (ANI): Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, announced today the launch of ...